The left might appreciate the accomplishment more if President Trump hadn’t named it after himself. That goes for Trump plans (which is putting egg on the face of proglodytes who bitch about corporations that are doing obscene amounts for the plans for the kids of their employees). But it’s called Trump plans.
We can’t (say the Dems).
So, for TrumpRx, which is a different thing, solving another problem Dems like to bitch about. Democrats only ever made it worse; in fact, a lot worse. Trump has intervened, but in a different way. There is still government force at play, but the government isn’t getting anything out of it, which is another reason Democrats have to hate it.
It’s called TrumpRx; we can’t. Oh, and where’s the kickback to the party?
There isn’t one. Mr. Trump just pulled the curtain back and asked, why do you charge them this and us that? Oh, and while you’re at it, we’d like to invite you to invest in America and Americans and make those drugs here. Do that, and we can revisit other matters of concern.
The Art of the Deal.
“The U.S. has now reached 26 such deals covering 89% of the branded drug market,” the Journal reported. It would be great enough that the nine new companies that signed agreements yesterday will offer most of their drugs to Medicaid —the largest single domestic drug buyer— at the lowest price paid by any developed nation. One of the nine was Teva— the world’s largest generic drug maker.
Saving Medicaid (or any federal gimme) has two critical vectors. Lowering costs without depriving legitimate beneficiaries of access, and denying access and money to anything and anyone who does not qualify. Doctors and hospitals have been making bank by milking Medicaid (and Medicare) for things and people it should not. Add the other sorts of fraud that have been uncovered, and there are trillions in savings available that will benefit everyone who is legally eligible, while saving taxpayers a small fortune.
The Democrat plan is to ignore the fraud, continue to allow ineligible participants to bleed taxpayers, and to infer that increased funding is the same as improving care and access. It’s not. We’ve been doing it that way for years, and the result is Democrats crying about outcomes while hiding, excusing, or ignoring blue-state criminal negligence labeled as oversight.
Nor is laundering drug money through third parties, benefits managers, and big Pharma, who might then see it as a reason to invest in the sort of politicians who keep that arrangement in place.
Second, as TrumpRx has gone from A handful of drugs to most drugs,
The Journal reported that the nine drugmakers “also agreed to collectively commit $19.6 billion to manufacturing in the U.S. in the near term.” So he got them to lower prices and commit to spending $20 billion to build permanent facilities here in the U.S., which is a negotiating tactic the literature refers to as sweeping the board.
Anyone getting upitty about tariffs needs to know that tariffs are why the drug makers are giving the US Government and US citizens lower prices and promises of domestic expansion (jobs, commerce, local tax revenue, etc.). Tariff threats got the deal done, which means democrats could undo it, and Big Pharma could go back to its higher US pricing structure.
On Monday, TDS-infested FactCheck.org ran a story conceding that, so far this year, 2026, drug prices have seen the largest one-year price drop since 1963, and the steepest six-month drop since the Bureau of Labor Statistics started tracking prescription drug costs in 1947. In other words, Trump just set the record. Nobody’s lowered prices faster than he has. Ever.
I’m not sure what the plan is for insurance, but it probably looks similar and ends with freer markets, Buffett plans, competition, and lower costs all around. It’d be a shame if we don’t get to see that because Republicans didn’t show up for the midterms to keep Dems from wrecking real progress.
